Therapy-related acute myeloid leukemia with t(8;16)(p11;p13) following anthracycline-based therapy for nonmetastatic osteosarcoma.

@article{Demuynck1995TherapyrelatedAM,
  title={Therapy-related acute myeloid leukemia with t(8;16)(p11;p13) following anthracycline-based therapy for nonmetastatic osteosarcoma.},
  author={Hilde Demuynck and Gregor E. G. Verhoef and Pierre Zach{\'e}e and Peter Vandenberghe and A van Orshoven and Robert J. Paridaens and I. Samson and M. A. Boogaerts},
  journal={Cancer genetics and cytogenetics},
  year={1995},
  volume={82 2},
  pages={103-5}
}
A case of therapy-related AML with t(8;16)(p11;p13) 14 months following the end of anthracycline-containing chemotherapy for a nonmetastatic osteosarcoma of the left tibia is presented. The patient was successfully treated with intensive remission-induction chemotherapy. Subsequently, he underwent an uncomplicated allogeneic bone marrow transplantation from his HLA-identical brother and is at present alive and disease-free 10 months after diagnosis of the secondary AML.